Cartesian Therapeutics (RNAC) Other Non Operating Income (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Other Non Operating Income of -$3000.0 for Q1 2026, up 99.85% quarter-over-quarter from -$2.0 million in Q4 2025.
Cartesian Therapeutics (RNAC) Other Non Operating Income (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Other Non Operating Income data on file, last reported at -$3000.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$3000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 2154.08% YoY), and the FY2025 annual result was -$2.0 million, down 431.68% from the prior year.
- Other Non Operating Income advanced to -$3000.0 in Q1 2026 per RNAC's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $652000.0 in Q4 2023 and troughed at -$2.0 million in Q4 2025.
- A 5-year average of -$43428.6 and a median of $21000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income jumped 25200.0% in 2023, then tumbled 351.58% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at -$177000.0 in 2022, then jumped by 468.36% to $652000.0 in 2023, then sank by 168.1% to -$444000.0 in 2024, then slumped by 351.58% to -$2.0 million in 2025, then jumped by 99.85% to -$3000.0 in 2026.
- Business Quant data shows RNAC's Other Non Operating Income at -$3000.0 in Q1 2026, -$2.0 million in Q4 2025, and -$5000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -2.01 Mn |
| Jun 30, 2025 | -5,000.00 |
| Dec 31, 2024 | -444,000.00 |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 292,000.00 |
| Mar 31, 2024 | 508,000.00 |
| Dec 31, 2023 | 652,000.00 |
| Sep 30, 2023 | 253,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | -177,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 515,000.00 |
| Sep 30, 2021 | -500,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Dec 31, 2020 | 589,000.00 |
| Sep 30, 2020 | -500,000.00 |
| Jun 30, 2020 | -42,000.00 |